Is Milk Bad for Your Liver? What the Science Says

Milk is not categorically bad for your liver, but the relationship is far from simple. Depending on the fat content, how the milk is processed, and whether you already have liver disease, the same glass of milk can shift from mildly protective to potentially harmful. A large prospective cohort study found that people who drank the most low-fat milk had roughly half the risk of dying from chronic liver disease compared to those who drank the least, while those who consumed the most high-fat milk had about double the risk. That single finding captures the tension running through the research: the type of dairy you choose matters as much as whether you drink it at all.

What Population Studies Show About Milk and Fatty Liver

Fatty liver disease, once considered mainly a consequence of heavy drinking, now affects a large portion of the global population through its metabolic form. Several large observational studies have looked at whether people who drink milk tend to have more or less liver fat. A study of over 5,000 adults in Iran found that higher milk consumption independently predicted a lower fatty liver index, with each additional unit of intake reducing the odds by about 4%.¹ A prospective Korean cohort found that men with the highest milk intake had about a quarter lower risk of developing metabolic fatty liver disease compared to men with the lowest intake, though the same protective pattern did not show up in women.² Another Korean dietary-pattern analysis found that people who followed a dairy-rich eating pattern had a lower cumulative incidence of fatty liver disease than those following carnivore, plant-based, or starch-rich patterns.³

These results paint a broadly favorable picture, but they come with an important caveat: most of these studies do not distinguish carefully between whole milk and skim milk, or between a glass of milk and a bowl of sweetened yogurt. When researchers have drilled into those differences, the picture becomes considerably more complicated.

Full-Fat Versus Low-Fat Makes a Striking Difference

If there is one consistent thread in the research, it is that the fat content of your dairy matters enormously. A large U.S. prospective cohort tracked chronic liver disease deaths and liver cancer cases over a median follow-up of about 15 years. People who consumed the most high-fat dairy had roughly 50% higher mortality from chronic liver disease, and those who drank the most high-fat milk specifically had about double the risk. In stark contrast, people who consumed the most low-fat dairy had about 38% lower mortality, and frequent low-fat milk drinkers had about 46% lower mortality.⁴

An analysis of NHANES data reinforced this split from the opposite direction. Adults who drank non-skimmed milk “sometimes” had roughly 67% higher odds of metabolic fatty liver disease compared to those who rarely drank it.⁵ Interestingly, the highest-frequency drinkers showed a smaller increase in risk that lost statistical significance after correction, hinting at a complicated dose-response that researchers have not fully explained yet.

Animal research supports the idea that fat content is the key variable. In a mouse model of early fatty liver disease, nonfat milk supplementation cut liver triglyceride content by about a third compared to a high-fat diet, and also increased markers of mitochondrial activity in the liver. Whole-fat milk still produced lower liver fat than a pure high-fat diet, but the nonfat version clearly outperformed it.⁶ The practical upshot: if you are concerned about liver health, the switch from whole milk to low-fat or skim milk is one of the more evidence-backed moves you can make within the dairy category.

How Milk Proteins Affect the Liver

Milk is roughly 80% casein and 20% whey protein, and these two protein families appear to influence the liver through different routes. Whey protein has attracted the most attention as a potential liver protectant. A review of clinical and preclinical evidence describes whey proteins as rich in essential amino acids with antioxidant properties that show promise for preventing and managing fatty liver disease across a spectrum of related problems including impaired glucose metabolism, inflammation, and oxidative stress.⁷

In a rat study, whey protein supplementation significantly reduced liver triglycerides, liver enzymes ALT and AST, and markers of oxidative damage, with liver biopsies showing near-normal appearance after treatment.⁸ A small human pilot study went further: patients with the more severe form of fatty liver disease (NASH) who took a cysteine-rich whey protein isolate for 12 weeks saw their liver enzymes drop, their antioxidant capacity rise, and their liver fat content decrease on imaging.⁹ That was a small, open-label study without a control group, so the results should be treated as preliminary. But the direction aligns with the animal data and with what we know about whey’s amino acid profile.

Casein tells a more mixed story. A hydrolyzed casein formulation reduced liver fat accumulation and lowered both free cholesterol and esterified cholesterol in a mouse model of fatty liver disease and atherosclerosis.¹⁰ Mice fed hydrolyzed casein also showed lower expression of genes involved in making new fat in the liver.¹¹ So casein in its broken-down form seems to help. But intact casein, when heated during processing, can form a compound called lactulosyllysine, and that compound has been linked to a different set of problems discussed in the section on processing below.

Fermented Dairy and the Gut-Liver Connection

Yogurt and kefir consistently look better for the liver than plain liquid milk in observational data. In the same large cohort study that found high-fat milk doubled liver disease mortality, frequent yogurt consumption was associated with about 40% lower mortality.⁴ The likely explanation involves the gut. Your liver receives blood directly from the intestines through the portal vein, so anything that improves gut barrier integrity or reduces gut-derived inflammation can ease the burden on the liver.

Kefir, a fermented milk drink, contains peptides and bacterial strains that can shift gut bacterial composition, tamp down low-grade inflammation, and reduce intestinal permeability, the “leaky gut” phenomenon that lets bacterial toxins slip into portal blood.¹² In mice fed a high-fat diet, yogurt fermented with a specific strain of Lactobacillus rhamnosus altered gut bacteria in ways that increased butyric acid production in the gut, which in turn activated a signaling pathway in the liver that suppressed fat synthesis and promoted fat burning.¹³ Fermented goat milk with another Lactobacillus strain reduced liver cell damage and oxidative injury in mice that were experimentally aged.¹⁴

The fermentation process itself may partly explain this. Bacteria break down some of the lactose before you consume it, and they generate short-chain fatty acids and bioactive peptides that liquid milk simply does not contain. It is one of the rare cases where the processed version of a food may be genuinely better for a specific organ than the raw ingredient.

The Milk Fat Globule Membrane, a Hidden Protector

Buried within milk fat is a thin membrane called the milk fat globule membrane, or MFGM. It is a complex layer of phospholipids and proteins that wraps each droplet of fat in milk. Research in animal models suggests MFGM has liver-protective properties independent of the fat it carries. In mice with induced colitis, MFGM administration reduced secondary liver injury by lowering hepatic oxidative stress and boosting the liver’s glutathione transferase pathway, one of its main detoxification systems.¹⁵ In a rat model of short bowel syndrome, which often causes liver complications, MFGM supplementation reduced liver fat buildup and inflammation scores while suppressing a key inflammatory signaling complex in liver tissue.¹⁶

MFGM is concentrated in whole milk and cream but largely absent from skim milk. This creates an interesting paradox: the component of whole milk that may be most protective for the liver comes packaged alongside the saturated fat that appears to harm it. Some supplement manufacturers have begun isolating MFGM from milk for standalone use, though human liver-specific trials are still lacking.

What About Lactose?

Lactose, the natural sugar in milk, often gets overlooked in liver discussions. A randomized crossover trial in humans tested what happens to liver fat-making after consuming lactose versus sucrose versus maltodextrin. Lactose boosted the liver’s rate of producing new fat to about 22%, a level statistically indistinguishable from the 23% seen after consuming table sugar. Both were significantly higher than the maltodextrin comparison.¹⁷ This makes sense biochemically: lactose is broken down into glucose and galactose, and galactose is processed almost entirely by the liver.

That said, the amount of lactose in a glass of milk is modest compared to, say, the amount of fructose in a can of soda. A typical glass of milk contains around 12 grams of lactose. The liver’s response to that sugar load in the context of a whole food, with its protein and fat slowing absorption, is likely different from a bolus of pure lactose given in a controlled trial. The finding does mean, though, that people who drink large quantities of milk daily are delivering a nontrivial sugar load to their liver, and this deserves consideration alongside the protein and calcium benefits.

Calcium, Vitamin D, and Liver Fat

Milk is a major dietary source of calcium and is frequently fortified with vitamin D. Both nutrients may independently benefit the liver. In rats fed a high-fat diet, combinations of calcium and vitamin D reduced body fat, lowered serum liver enzymes, and decreased hepatic fat accumulation and visible fatty liver changes.¹⁸ The strongest effects appeared at the highest calcium-plus-vitamin-D dose. This may partly explain why dairy-rich diets show protective associations in observational studies even when the milk itself is not particularly special: people who drink milk get calcium and vitamin D that many non-dairy-drinkers miss.

Heat Processing and Advanced Glycation End Products

Here is where milk’s reputation gets legitimately muddier. When milk is heat-treated, which includes pasteurization and especially ultra-high-temperature (UHT) processing, the natural sugars react with the proteins to form compounds called advanced glycation end products, or AGEs. A specific one, lactulosyllysine, forms when lactose reacts with the amino acid lysine in casein during heating. Research has found that casein-bound lactulosyllysine gets metabolized in the body into a reactive compound that promotes carbonyl stress, leading to accumulation of AGEs in tissues and triggering systemic inflammation.¹⁹

Long-term feeding of casein-bound lactulosyllysine to mice induced fatty liver disease in non-obese animals by impairing a key energy-sensing pathway and disrupting the liver’s ability to export fat-carrying particles into the blood.²⁰ More broadly, diets high in AGEs from heat-processed foods have been shown in mice to cause fat accumulation, oxidative stress, inflammation, and fibrosis in the liver, and to disrupt lipid metabolism at the gene expression level.²¹ In an animal model of existing fatty liver disease, adding high-AGE foods to the diet worsened liver injury, inflammation, and fibrosis through oxidative stress and a specific receptor-driven pathway in the liver’s scarring cells.²²

This is not unique to milk. Browning a steak, toasting bread, or frying anything produces AGEs. But milk is one of the few foods where heat treatment is legally required for safety yet may introduce compounds that stress the liver. The doses used in animal studies typically exceed what you would get from ordinary milk consumption, so the real-world relevance for someone drinking a glass or two a day is uncertain. It does, however, suggest that UHT shelf-stable milks, which undergo more intense heating, may carry a higher AGE load than conventionally pasteurized milk.

Dairy and Liver Cancer Risk

The relationship between milk and liver cancer deserves its own discussion because it runs in a different direction from the fatty liver data. The European Prospective Investigation into Cancer and Nutrition (EPIC), one of the largest prospective cohorts in Europe, found that people in the highest third of total dairy consumption had about 66% higher risk of hepatocellular carcinoma compared to those in the lowest third. Milk and cheese drove the association, while yogurt showed no link.²³ The large U.S. cohort mentioned earlier found a marginally positive association between total dairy and high-fat dairy consumption and liver cancer risk, with milk intake specifically linked to hepatocellular carcinoma.⁴

One proposed mechanism involves growth signaling. Milk proteins, particularly the branched-chain amino acids concentrated in both whey and casein, along with milk’s saturated fat, can activate a growth-promoting signaling pathway in the liver called mTORC1, partly through boosting IGF-1 levels.²⁴ This is the same pathway that helps milk support growth in infants and muscle building in adults. In a liver already burdened by chronic disease or inflammation, persistent activation of growth signals could theoretically tip the balance toward cancer. This remains a mechanistic hypothesis built partly on animal data and partly on epidemiological correlation, not a proven causal chain. But it does complicate the “milk is good for your liver” narrative and suggests that the answer may depend on whether your liver is healthy to begin with.

Aflatoxin M1 in Milk Supply Chains

A concern that is geographic but worth knowing about: aflatoxin contamination. When dairy cows eat feed contaminated with aflatoxin B1, a potent fungal toxin, their livers metabolize it into aflatoxin M1 (AFM1), which then shows up in their milk. In a study of raw milk from Ethiopia’s North Shewa Zone, AFM1 was detected in about 84% of samples, with nearly 59% exceeding the European Commission’s maximum permissible limit.²⁵ The researchers estimated a cancer risk of about 0.0017 hepatocellular carcinoma cases per 100,000 people per year from AFM1 exposure at the observed contamination levels. Aflatoxins damage the liver and are established carcinogens, and chronic low-level exposure from contaminated dairy is an acknowledged liver cancer risk factor in parts of sub-Saharan Africa, South Asia, and Southeast Asia.²⁶

In the United States, European Union, and other strictly regulated markets, AFM1 levels in commercial milk are monitored and generally kept well below the levels found in the Ethiopian study. This does not mean the risk is zero, but for most readers in regulated markets, it is not a practical concern with pasteurized commercial milk. For people in regions with less stringent dairy safety infrastructure, it is a legitimate liver-health issue that goes beyond milk’s nutritional profile.

Milk When You Already Have Liver Disease

If you have cirrhosis or advanced liver disease, the old clinical advice was to restrict protein intake, especially animal protein, to reduce blood ammonia levels and prevent hepatic encephalopathy, a condition where toxins that the damaged liver cannot clear affect brain function. That advice has fallen out of favor. A review of dietary interventions for liver cirrhosis notes that earlier studies on protein restriction failed to account for the role of fermentable fiber, which reduces ammonia absorption in a way similar to lactulose, the standard drug treatment.²⁷ In other words, the apparent benefit of cutting protein may actually have come from the fiber that replaced it.

A recent clinical trial tested a diet based on vegetable and dairy protein in cirrhosis patients with sarcopenia, the muscle wasting that frequently accompanies advanced liver disease. Over 12 weeks, blood ammonia stayed stable in the dairy-and-vegetable protein group while it rose significantly in the control group eating a standard diet. The between-group difference in ammonia was statistically significant.²⁸ The dairy-and-vegetable group also saw improvements in functional measures like grip strength and walking speed, though these did not reach statistical significance compared to the control group. For people with cirrhosis, dairy protein appears at minimum to be a safer alternative to red meat as a protein source, and may actively help manage ammonia levels while preserving muscle.

Putting the Pieces Together Without Oversimplifying

The research does not support an all-or-nothing verdict on milk and liver health. The most consistent finding is that fat content is the critical variable. Low-fat and fermented dairy products are associated with less liver fat, lower liver disease mortality, and metabolic benefits that operate through the gut, through calcium and vitamin D, and through whey protein’s antioxidant amino acids. Whole milk and high-fat dairy flip several of those associations into risk territory, particularly for liver disease progression and possibly liver cancer. Heat processing adds another layer by generating compounds that stress the liver in ways unrelated to fat content. And the benefits of milk’s protein components, clearly demonstrated for whey, depend partly on whether the protein is consumed as part of a fermented product, a processed liquid, or an isolated supplement.

For someone with a healthy liver who drinks moderate amounts of low-fat milk or eats yogurt regularly, the evidence leans mildly positive. For someone who drinks large amounts of whole milk, particularly UHT-processed milk, while carrying other liver risk factors like obesity or heavy alcohol use, the evidence suggests reason for caution. And for people with cirrhosis, dairy protein in reasonable amounts appears to be not just safe but potentially preferable to meat-heavy protein sources for managing the metabolic complications of advanced liver disease.